Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The gross margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
GROSS MARGIN
0.00%
GROSS MARGIN AVG TTM
0.00%
GROSS MARGIN AVG 3Y
0.00%
GROSS MARGIN AVG 5Y
0.00%
GROSS MARGIN AVG 10Y
0.00%
GROSS MARGIN AVG 15Y
0.00%
GROSS MARGIN AVG 20Y
8.58%
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
-100.00%
SECTOR MEDIAN · HEALTHCARE
41.38%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
-100.00%
vs the sector median at left
Market Cap
$8.04M
Gross Margin
N/A
TTM Avg
-2933.43%
3Y Avg
-1696.98%
5Y Avg
-1166.77%
Market Cap
$8.19M
Gross Margin
-41.30%
TTM Avg
-15.77%
3Y Avg
-3.50%
5Y Avg
-3.50%
Market Cap
$7.92M
Gross Margin
0.00%
TTM Avg
-261.58%
3Y Avg
-106.09%
5Y Avg
-70.73%
Market Cap
$7.90M
Gross Margin
100.00%
TTM Avg
97.34%
3Y Avg
98.67%
5Y Avg
99.12%
Market Cap
$8.34M
Gross Margin
18.37%
TTM Avg
19.16%
3Y Avg
20.84%
5Y Avg
23.00%
Market Cap
$7.76M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$7.65M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$7.56M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| GT Biopharma, Inc. (GTBP) | $8.11M | 0.00% | 0.00% | 0.00% | 0.00% |
| HeartSciences Inc. (HSCS)vs › | $8.04M | N/A | -2933.43% | -1696.98% | -1166.77% |
| DataMEDS AI, Inc. (MEDS)vs › | $8.19M | -41.30% | -15.77% | -3.50% | -3.50% |
| Aprea Therapeutics, Inc. (APRE)vs › | $7.92M | 0.00% | -261.58% | -106.09% | -70.73% |
| Traws Pharma, Inc. (TRAW)vs › | $7.90M | 100.00% | 97.34% | 98.67% | 99.12% |
| Healthcare Triangle, Inc. (HCTI)vs › | $8.34M | 18.37% | 19.16% | 20.84% | 23.00% |
| CNS Pharmaceuticals, Inc. (CNSP)vs › | $7.76M | 0.00% | 0.00% | 0.00% | 0.00% |
| ENDRA Life Sciences Inc. (NDRA)vs › | $7.65M | 0.00% | 0.00% | 0.00% | 0.00% |
| Quince Therapeutics, Inc. (QNCX)vs › | $7.56M | 0.00% | 0.00% | 0.00% | 0.00% |
| InMed Pharmaceuticals Inc. (INM)vs › | $7.36M | 14.92% | 28.44% | 28.69% | 27.44% |
Gross Margin
0.0%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | 0.00% |
| 2016-12-31 | 0.00% |
| 2016-09-30 | 0.00% |
| 2016-06-30 | 0.00% |
| 2016-03-31 | 0.00% |
| 2015-12-31 | 0.00% |
| 2015-09-30 | -66.67% |
| 2015-06-30 | 100.00% |
| 2015-03-31 | 100.00% |
| 2014-12-31 | -6.06% |
| 2014-09-30 | -66.67% |
| 2014-06-30 | 32.00% |
| 2014-03-31 | 0.00% |
| 2013-12-31 | 46.34% |
| 2013-09-30 | 32.79% |
| 2013-06-30 | 78.57% |
| 2013-03-31 | 21.59% |
| 2012-12-31 | 72.15% |
| 2012-09-30 | 73.33% |
| 2012-06-30 | 100.00% |
| 2012-03-31 | 0.00% |
| 2011-12-31 | 100.00% |
| 2011-09-30 | -300.00% |
| 2011-06-30 | -1400.00% |
| 2011-03-31 | -25.00% |
| 2010-12-31 | -490.91% |
| 2010-09-30 | 0.00% |
| 2010-06-30 | 0.00% |
| 2010-03-31 | 0.00% |
| 2009-12-31 | -100.00% |
| 2009-09-30 | 0.00% |
| 2009-06-30 | 42.86% |
| 2009-03-31 | 0.00% |
| 2008-12-31 | 50.48% |
| 2008-09-30 | -24.44% |
| 2008-06-30 | 50.00% |
| 2008-03-31 | 43.98% |
| 2007-12-31 | 23.11% |
| 2007-09-30 | 51.28% |
| 2007-06-30 | 57.36% |
| 2007-03-31 | 47.59% |
| 2006-12-31 | 49.10% |
| 2006-09-30 | 52.05% |
| 2006-06-30 | 38.57% |
| 2006-03-31 | 46.07% |
| 2005-12-31 | 43.65% |
| 2005-09-30 | 37.41% |
| 2005-06-30 | 48.29% |
| 2005-03-31 | 54.68% |
| 2004-12-31 | 7.07% |
| 2004-09-30 | 70.44% |
| 2004-06-30 | 45.03% |
| 2004-03-31 | 44.44% |
| 2003-12-31 | 41.96% |
| 2003-09-30 | 54.46% |
| 2003-06-30 | 30.71% |
| 2003-03-31 | 59.93% |
| 2002-12-31 | 52.84% |
| 2002-09-30 | 43.43% |
